Patents
Patents for C07K 19 - Hybrid peptides (29,428)
08/2009
08/05/2009CN100523188C Platlet glycoprotein IB alpha fusion polypeptides and methods of use thereof
08/05/2009CN100523187C Modified chimeric polyeptides with improved pharmacokinetic properties
08/05/2009CN100522242C Artificial proteins with reduced immunogenicity
08/04/2009US7569663 Genetically engineered fusion proteins for use in diagnosis and treatment of cancer, viral infections, autoimmune and alloimmune diseases
08/04/2009US7569544 drug biological conjugates used in the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers
08/04/2009US7569387 Specifically binds an MK61 polypeptide produced by immunizing an animal
08/04/2009US7569226 Alkaline protease from Bacillus sp. (DSM 14392) and washing and cleaning products comprising said alkaline protease
08/04/2009US7569225 Immunogenic lipopeptides comprising T-helper and B-cell epitopes
08/04/2009CA2323090C In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases
08/04/2009CA2194673C A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
07/2009
07/30/2009WO2009093118A1 Cell surface display of proteins
07/30/2009WO2009068042A3 Novel peptides derived from ncam (fgls)
07/30/2009WO2008145013A8 Fusion protein comprising targeting peptide of cd13 and lidamycin
07/30/2009US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides
07/30/2009US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist
07/30/2009US20090191624 Use of transthyretin peptide/protein fussions to increase the serum half-life of pharmacologically active peptides/proteins
07/30/2009US20090191581 Cell-permeable fluorescent proteins
07/30/2009US20090191234 Vaccine
07/30/2009US20090191196 Use
07/30/2009US20090191154 Assembly and folding of fc-interferon-beta fusion proteins
07/29/2009EP2083079A1 Apo-2DcR
07/29/2009EP2083073A1 Reagent containing fused protein of soluble rankl with epitope tag
07/29/2009EP2083018A2 Compositions and methods relating to STOP-1
07/29/2009EP2083016A1 Bacterial superantigen vaccines
07/29/2009EP2082042A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens
07/29/2009EP1549679B1 Fusion protein comprising angiopoietin receptor-binding and a multimerization domain
07/29/2009EP1002110B2 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins
07/29/2009CN101495516A CD33-specific single-chain immunotoxin and method of use
07/29/2009CN101492508A Streptavidin/interleukins 15 amalgamation protein
07/29/2009CN100519585C Fusion protein of P11 and SAK and its preparation method and use
07/28/2009US7566777 Genes encoding hormone and lytic peptides
07/28/2009US7566694 Anti-pathogen treatments
07/28/2009US7566566 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
07/28/2009US7566559 Human cyclin-dependent kinase (hPNQALRE)
07/28/2009US7566457 Proteins for use as vaccine to prevent dengue virus infection; immunotherapy; high serotype-specificity to be used in humans
07/23/2009WO2009090933A1 Virus growing in hypoxic cell or virus vector expressing gene therein
07/23/2009WO2009064255A8 N-terminal xa27 signal anchor and its use for localization of fusion proteins
07/23/2009WO2008127179A8 Fusion protein vaccine
07/23/2009US20090186822 Thrombopoietic Compounds
07/23/2009US20090186820 Streptococcus pyogenes polypeptides and corresponding dna fragments
07/23/2009US20090186409 Compositions and methods for the diagnosis and treatment of tumor
07/23/2009US20090185979 Integrin Heterodimer and an Alpha Subunit Thereof
07/22/2009EP2080804A1 Modified cytokines for use in cancer therapy
07/22/2009EP2080772A2 Recombinant polypeptides and methods for detecting and/or quantifying autoantibodies against TSH receptor
07/22/2009EP2080771A2 New interferon beta-like molecules
07/22/2009EP2079840A1 Immunotox n fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers
07/22/2009EP2079526A1 Compositions and uses thereof in the treatment of wounds
07/22/2009EP1280900B1 Dendritic cell co-stimulatory molecules
07/22/2009EP1220922B1 Method of identifying a compound with efficacy in the treatment of chronic inflammatory diseases
07/22/2009CN101486768A Antigen protein for treating Alzheimer's disease and protein gene
07/22/2009CN101486759A Human Toll-like receptor protein, related reagent and method
07/22/2009CN100516215C Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation
07/22/2009CN100516087C Recombinant target fusion protein GnRH-TNFam and its antitumor use
07/21/2009US7563882 Comprises polypeptide for diagnosis and treatment of tumors; immunotherapy
07/21/2009US7563876 For binding and blocking human mannose receptors; fibronectins; immunoglobulins; cd antigens; cytolysis; cytotoxic lymphocytes; for treatment of automimmune diseases
07/21/2009US7563760 P-selectin ligand protein
07/21/2009US7563439 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue; radioimmunotherapy
07/21/2009CA2329144C New peptide fragments for protein purification
07/21/2009CA2133834C Process for preparing modified proteins
07/16/2009WO2009089186A2 Peptide-conjugated oligonucleotide therapeutic and method of making and using same
07/16/2009WO2009087508A1 Production of heterologous proteins or peptides
07/16/2009US20090181894 Chimeric toxins for targeted therapy
07/16/2009US20090181049 Capsular polysaccharide solubilisation and combination vaccines
07/16/2009US20090181045 Tat-based vaccine compositions and methods of making and using same
07/16/2009US20090181041 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof
07/16/2009US20090181024 Novel composition and methods for the treatment of immune related diseases
07/16/2009US20090181011 Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors
07/16/2009CA2711691A1 Barb4 target, antibody designated barb4, barb4 related antibodies, and methods of making and using same
07/15/2009EP2078086A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof
07/15/2009EP2078082A1 Recombinant human interferon-like proteins
07/15/2009EP2078041A2 Fusion proteins comprising two or more igg binding domains of streptococcal protein g.
07/15/2009EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer
07/15/2009EP1214097B1 Nucleic acids encoding polyepitope polypeptides
07/15/2009CN101484472A Improved sgp130Fc dimers
07/15/2009CN101481422A Antineoplastic target fusion protein with release switch and use thereof
07/15/2009CN101481421A Recombinant antigen polypeptide for treating Alzheimer's disease and polypeptide gene
07/15/2009CN101481420A Heterozygous antibacterial peptide CA-MA and recombinant expression method thereof
07/15/2009CN101481419A Fusion protein of beta 2-microglobulin and green fluorescent protein, preparation and use thereof
07/15/2009CN101481418A Fusion protein of tumor vascular targeted peptide and novel tumor necrosis factor
07/15/2009CN100513548C Improved methods for binding AcmA-type protein anchor fusions to cell-wall material of micro-organisms
07/14/2009US7560540 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
07/14/2009US7560529 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence
07/14/2009US7560441 Modified and stabilized GDF propeptides and uses thereof
07/14/2009US7560431 administering drug biological conjugates used for the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers
07/14/2009US7560250 comprise a large heterologous polypeptide, such as a membrane protein, fused to a small soluble carrier polypeptide, which can be expressed by recombinant host cells in amounts and with solubility, purifiability and stability under crystallization conditions enabling their high-grade crystallization
07/14/2009CA2382302C A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis
07/10/2009CA2617691A1 Translocator component derivatives and uses thereof
07/09/2009WO2009086126A2 Natriuretic polypeptides
07/09/2009WO2008040190A8 Small peptides for anti-angiogenesis and use thereof
07/09/2009WO2007112675A8 Vegf receptor fusion protein and use thereof
07/09/2009WO2007109697A8 The use of protein s fusion for protein solubilization
07/09/2009WO2007098548A8 A molecule and chimeric molecules thereof
07/09/2009WO2007098547A8 A molecule and chimeric molecules thereof
07/09/2009US20090176657 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds
07/09/2009US20090176276 Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide
07/09/2009US20090175912 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system
07/09/2009US20090175893 Albumin-Fused Anti-Angiogenesis Peptides
07/09/2009US20090175858 Crystalline EGFR - matuzumab complex and matuzumab mimetics obtained thereof
07/09/2009US20090175850 NOGO Receptor Homologs
07/09/2009US20090175821 Modified therapeutic peptides with extended half-lives in vivo
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 295